Enhance your practice with CMEand tools that focus on the managementand treatment of patients with cancer.
Debunking CAR T-Cell Myths: The Realities of Patient Selection, Safety, and Access
Charles Turck, PharmD, BCPS, BCCCP
Matthew Lunning, DO, FACP
Assessing Efficacy and Cost of Blood-Based Tests for Colorectal Cancer
Samuel Muench, MD
Biomarker Breakthroughs: A Look at What’s Next for Kidney Cancer Care
Ryan Quigley
David F. McDermott, MD
New Frontiers in the Imaging and Treatment of Advanced Prostate Cancer
Wayne Kuang, MD
William Oh, MD
Unpacking the Logistics of At-Home Subcutaneous Cancer Immunotherapy Delivery
Jorge Nieva, MD
Bringing Cancer Care Home: How Subcutaneous Immunotherapy Can Help Ease the Burden
Why Words Matter: Rethinking Terminology in Advanced Prostate Cancer
Androgen Receptor Emerges as a Marker of Differentiation in Endometrial Cancer
Chemotherapy Strategies in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
Eileen O’Reilly, MD
Efrat Dotan, MD
First-line Chemotherapy Options in Metastatic PDAC
Mutational Testing in mCRC: Methods and Data Driving Treatment Selection
Fortunato Ciardiello, MD, PhD
Jenny Seligmann, MBChB, PhD
Mastering Mutation-Driven mCRC: From Testing to Targeted Therapy
Liquid Biopsy for Colorectal Cancer Screening: Benefits and Barriers
Brennan Spiegel, MD, MSHS
Subcutaneous Cancer Immunotherapy at Home: Transforming Trials and Patient Care
Early-Onset Endometrial Cancer: Bridging the Gap Between Age and Outcome
Investigating At-Home Subcutaneous Atezolizumab for NSCLC: An Ongoing Study
Studying Carboplatin-Paclitaxel + Retifanlimab for Squamous Cell Carcinoma of the Anal Canal
Richard Kim, MD
Uncovering Unmet Needs in Squamous Cell Carcinoma of the Anal Canal Care
Stratifying ICI-P Risk in Non-Small Cell Lung Cancer with Genetic and Radiographic Markers
Immune Checkpoint Inhibitors Show Promise in Patients with Oncogene Driver-Negative NSCLC Who Have Never Smoked
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.